Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vaccine Safety”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT05137444
What this trial is testing

Phase Ⅱ and Ⅲ Trial of a SARS-CoV-2 Vaccine LYB001

Who this might be right for
COVID-19
Yantai Patronus Biotech Co., Ltd. 1,900
Testing effectiveness (Phase 2)Study completedNCT00895544
What this trial is testing

Immunogenicity and Safety Study of a Single Prime-Boost Vaccination Schedule With a H5N1 Influenza Vaccine in Adults

Who this might be right for
InfluenzaAvian Influenza
Alachua Government Services, Inc. 231
Large-scale testing (Phase 3)Study completedNCT04313244
What this trial is testing

Immunogenicity and Safety of Dengue Tetravalent Vaccine (TDV) and Recombinant 9-valent Human Papillomavirus Vaccine (9vHPV) in Participants Aged ≥9 to <15 Years

Who this might be right for
Dengue Fever
Takeda 614
Testing effectiveness (Phase 2)Study completedNCT02425098
What this trial is testing

Safety and Immunogenicity With Two Different Serotype 2 Potencies of Takeda's Tetravalent Dengue Vaccine Candidate (TDV) in Adults in Singapore

Who this might be right for
Dengue Fever
Takeda 351
Large-scale testing (Phase 3)Study completedNCT01153893
What this trial is testing

Immunization of Children Previously Primed With GSK Pneumococcal Vaccine GSK1024850A and of Unprimed Children in Nigeria

Who this might be right for
Infections, Streptococcal
GlaxoSmithKline 105
Early research (Phase 1)Ended earlyNCT03948763
What this trial is testing

MRNA-5671/V941 as Monotherapy and in Combination With Pembrolizumab (V941-001)

Who this might be right for
NeoplasmsCarcinoma, Non-Small-Cell LungPancreatic Neoplasms+1 more
Merck Sharp & Dohme LLC 70
Large-scale testing (Phase 3)Active Not RecruitingNCT07135986
What this trial is testing

Immunogenicity and Safety Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children and Adolescents in China

Who this might be right for
Meningococcal InfectionHealthy Volunteers
Sanofi 1,602
Early research (Phase 1)UnknownNCT02015494
What this trial is testing

Phase 1 Safety Study of Recombinant Influenza Vaccine for Prevention

Who this might be right for
Influenza
VaxInnate Corporation 316
Early research (Phase 1)Study completedNCT00082069
What this trial is testing

Invaplex 50 Vaccine Dose-Ranging

Who this might be right for
Diarrhea
U.S. Army Medical Research and Development Command 32
Post-approval studies (Phase 4)Study completedNCT00586469
What this trial is testing

Study to Compare the Safety and Immunogenicity of Fluviral® Made With New Versus Aged Bulk

Who this might be right for
Influenza Vaccines
GlaxoSmithKline 1,000
Testing effectiveness (Phase 2)Study completedNCT02302066
What this trial is testing

Safety and Immunogenicity of Different Schedules of Takeda's Tetravalent Dengue Vaccine Candidate (TDV) in Healthy Participants

Who this might be right for
Dengue Fever
Takeda 1,800
Large-scale testing (Phase 3)Study completedNCT00345956
What this trial is testing

To Evaluate Immunogenicity, Reactogenicity & Safety of 2 Doses of GSK Bio HRV Liquid Vaccine Given to Infants (Vietnam)

Who this might be right for
Infections, Rotavirus
GlaxoSmithKline 375
Post-approval studies (Phase 4)Study completedNCT02908269
What this trial is testing

Safety and Immunogenicity of Fluzone® Quadrivalent and Fluzone® High-Dose, Influenza Vaccines, 2016-2017 Formulations

Who this might be right for
Influenza
Sanofi Pasteur, a Sanofi Company 180
Large-scale testing (Phase 3)Study completedNCT04841369
What this trial is testing

Phase III Clinical Trial of a Candidate PCV13 in Healthy People Aged 6 Weeks and Above (PICTPCV13i)

Who this might be right for
Pneumococcal InfectionsStreptococcal InfectionsBacterial Infections
CanSino Biologics Inc. 3,420
Testing effectiveness (Phase 2)UnknownNCT05205083
What this trial is testing

Immunogenicity and Safety of Booster Immunization of ZF2001 After Inoculation With Two Doses of BBIBP-CorV

Who this might be right for
COVID-19
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 480
Early research (Phase 1)UnknownNCT04445194
What this trial is testing

Phase I Clinical Study of Recombinant Novel Coronavirus Vaccine

Who this might be right for
Coronavirus
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 50
Large-scale testing (Phase 3)Ended earlyNCT05281094
What this trial is testing

Efficacy and Safety of Two Doses of HIL-214 in Children

Who this might be right for
Gastroenteritis
HilleVax 3,084
Testing effectiveness (Phase 2)Study completedNCT00985673
What this trial is testing

Safety and Immunogenicity of H1N1 Vaccine With Trivalent Inactivated Seasonal Influenza Vaccine in Adults

Who this might be right for
Influenza
GlaxoSmithKline 611
Early research (Phase 1)Study completedNCT01072786
What this trial is testing

Evaluation of the Safety and Immune Response of Five Admixtures of a Tetravalent Dengue Virus Vaccine

Who this might be right for
Dengue
National Institute of Allergy and Infectious Diseases (NIAID) 141
Post-approval studies (Phase 4)Study completedNCT05432141
What this trial is testing

A Safety Study of Sabin Inactivated Poliovirus Vaccine in Infants

Who this might be right for
Poliomyelitis
Sinovac Biotech Co., Ltd 3,200
Next Page